Last reviewed · How we verify

NCT07370376

Ultrasonographic of Diaphragmatic Function in Obstructive Sleep Apnea

Completed Last updated 27 January 2026
What this trial tests

trial in OSA in 60 participants. Completed in 1 March 2024.

Timeline
1 March 2023
Primary endpoint
1 September 2023
1 March 2024

Quick facts

Lead sponsorMansoura University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date1 March 2023
Primary completion1 September 2023
Estimated completion1 March 2024
Sites1 location across Egypt

Conditions studied

Sponsor

Mansoura University

Who can join

18 and older, any sex, with OSA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obstructive sleep apnea (OSA) is associated with altered respiratory mechanics, including diaphragmatic function. Ultrasonography provides a non-invasive tool to assess diaphragmatic structure and performance, which may correlate with OSA severity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for OSA

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07370376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing